A guide to the therapeutic pipeline for new vaccines in Canada

The purpose of this guide is to describe how new vaccines are developed, tested, reviewed and approved, manufactured, and eventually used and monitored for safety and effectiveness in Canada. This multi-stage process is known as the “therapeutic pipeline.”  

Download guide (.pdf)

Who is this guide for?  

This guide is for anyone seeking to understand how new vaccines move through the different stages of the therapeutic pipeline in Canada. While this guide brings together technical information on these stages, it also offers an understanding of how social, economic and ethical issues are embedded along the pipeline.  

This document is intended to serve as a reference guide for anyone involved at specific stages of the pipeline and who wishes to have a basic understanding of other stages. The guide is particularly valuable for those involved in immunization policy and practice who may, in turn, be required to answer questions or respond to concerns about specific stages of the pipeline. This includes public health practitioners, healthcare providers, educators, government officials and industry representatives. 

Note: The therapeutic pipeline is continually evolving. This guide provides a framework for understanding the overall process in Canada and reflects our best understanding as of November 2026. For current processes and requirements, consult the relevant organizations’ latest guidance.

Related Activities/Resources

About Us

A national consortium of social sciences and humanities scholars.

Learn more